Ozlem Tureci

Ji Wîkîpediya, ensîklopediya azad.
Jump to navigation Jump to search
Ozlem Tureci
Ozlem Tureci v2.jpg
Ozlem Tureci in 2019
Jidayikbûn 6ê adara 1967an(1967-03-06) (54 salî)
Lastrup, Almaniya
Hevwelatî Germany
Perwerde
Pîşe
  • Chief Medical Officer
  • Chief Executive Officer
  • Company Founder
Salên çalak 1992–heya roja îro 28.2.2021
Karder
Rêxistin
  • American Society of Clinical Oncology
  • American Association for Cancer Resarch
  • German Society for Immunology
  • German Society for Hematology and Oncology
Sedema navdarbûnê
Meqam CMO BioNTech SE
Dewr 2018–heya roja îro 28.2.2021
Hevjîn Uğur Şahin (zw. 2002)
Zarok 1
Xelat
  • Calogero Pagliarello Research Award
  • Georges Köhler Prize
  • German Sustainability Award
  • Axel Springer Award
Malper Profile at BioNTech
biguherîneBelge

Lemzlem Türeci ( z.di 6ê Adarê 1967 de) bijîşk, zanyar û karsazek Alman e. Wê di 2008-an de hevkariya pargîdaniya biyoteknolojî ya Alman BioNTech -ê damezirand, ku vakslêdana yekem-pejirandî ya RNA-based Messenger ya li dijî (COVID-19) di sala 2020 -an de pêşxist. Türeci ji 2018-an vir ve wezîfedarê bijîşkî ye [1] Ew ji 2008an heya 2016an damezrîner û CEOyê Dermanfiroşên Ganymed bû. [2] [3] Türeci û hevjînê wê, Uğur Şahin, di sala 2020-an de di nav 100 kesên herî dewlemend ên Almanyayê de bûn. [4]

Jiyan û perwerde[biguherîne | çavkaniyê biguherîne]

BioNTech[biguherîne | çavkaniyê biguherîne]

Navenda Main of BioNTech

Endamtî[biguherîne | çavkaniyê biguherîne]

Ew endama Komeleya Onkolojiya Klînîkî ya Amerîkî (ASCO) ye. Komeleya Amerîkî ya ji bo Lêgerînê çerserên nexweşiyên şêrpenceyê (AACR), German Society of Immunology (de), û German Society of Hematology and Oncology (de)

Xelat[biguherîne | çavkaniyê biguherîne]

Çavkanî[biguherîne | çavkaniyê biguherîne]

  1. "Das Führungsteam", Homepage (bi elmanî), BioNTech, ji orîjînalê di 2020-12-10 de hat arşîvkirin, roja wergirtinê: 2020-11-30
  2. Vorlesungsverzeichnis, Johannes Gutenberg Universität Mainz, roja wergirtinê: 2020-11-30
  3. "Privatdozentin Dr. Özlem Türeci", DFG - GEPRIS - (bi elmanî), Deutsche Forschungsgemeinschaft, roja wergirtinê: 2020-11-30
  4. Philip Oltermann (November 10, 2020), Uğur Şahin and Özlem Türeci: German 'dream team' behind vaccine, The Guardian, ji orîjînalê di 17 January 2021 de hat arşîvkirin, roja wergirtinê: February 6, 2021, The comments hinted at the scientific rigour, unrelenting work ethic and appetite for entrepreneurship that has seen Sahin and Türeci’s company outpace more well-established competitors in the race for a Covid-19 vaccine – and made the couple the first Germans with Turkish roots to enter their country’s rich list this autumn, at number 93.
  5. Preisträger Vincenz-Czerny-Preis und deren Arbeiten (bi elmanî), Deutsche Gesellschaft für Hämatologie und Medizinische Onkologie, roja wergirtinê: 26 October 2020
  6. Ugur Sahin, Managing Director (Science and Research) of Translational Oncology at the University Medical Center of the Johannes Gutenberg University Mainz – Tron (bi îngilîzî), University of Birmingham, roja wergirtinê: 26 October 2020
  7. "Erfolgreiche Suche nach Tumormarkern", Ärzte Zeitung (bi elmanî), Springer Medizin, 13 October 2005, roja wergirtinê: 26 October 2020
  8. Koehler-Preis (bi elmanî), Deutsche Gesellschaft für Immunologie, roja wergirtinê: 26 October 2020
  9. "Deutscher Nachhaltigkeitspreis: Startseite", Deutscher Nachhaltigkeitspreis (bi elmanî), roja wergirtinê: 17 December 2020
  10. Miller, Joe; Cookson, Clive (16 December 2020), "FT People of the Year: BioNTech's Ugur Sahin and Ozlem Tureci", Financial Times, roja wergirtinê: 17 December 2020
  11. "Axel Springer Award 2021 geht an Biontech-Gründer", Die Welt, 2020-12-23, roja wergirtinê: 2020-12-23